SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAbrdn Di&g Regulatory News (ADIG)

  • This share is currently suspended. It was suspended at a price of 13.33

Share Price Information for Abrdn Di&g (ADIG)

Share Price is delayed by 15 minutes
Get Live Data
13.33    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £40.16m
ADIG Live PriceLast checked at - London Stock Exchange

Intraday Abrdn Di&g Share Chart

Interim Dividend

5 Mar 2026 07:00

RNS Number : 3862V
abrdn Diversified Income and Growth
05 March 2026
 

5 March 2026

For Immediate Release

ABRDN DIVERSIFIED INCOME AND GROWTH PLC

(the "Company")

Interim Dividend

The Board of the Company announces that it is declaring an interim dividend of 0.50 pence per share on the ordinary shares of the Company (the "Interim Dividend"), being approximately £1.5 million in aggregate.

The Interim Dividend will be paid on 26 March 2026 to shareholders on the register at 6.00 p.m. on 13 March 2026. The ex-dividend date for the Interim Dividend is 12 March 2026.

There will not be an option to elect to receive shares, in place of a cash dividend, under the Company's dividend reinvestment plan.

As set out in the circular to shareholders published by the Company on 17 June 2024, the Board intends to continue to pay a sufficient level of dividend to ensure that the Company will not retain more than 15 per cent. of its income in an accounting period in order to maintain the Company's investment trust status during its managed wind-down.

The Interim Dividend is in addition to the forthcoming return of capital pursuant to the Company's B share scheme described in the announcement made by the Company on 11 February 2026 (the "2026 Return of Capital"). The proceeds from the 2026 Return of Capital, which are equivalent to 14.5 pence per ordinary share (subject to rounding down for fractional entitlements), will be sent to uncertificated Shareholders through CREST, and to certificated Shareholders via cheque or electronic payment (if there is an electronic payment mandate on file), by 9 March 2026. 

Enquiries:

abrdn Holdings Limited

Secretaries

 

Email: cef.cosec@aberdeenplc.com

 

The Company's LEI number is 2138003QINEGCHYGW702.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVDZLFBQXLZBBX
Date   Source Headline
11th Dec 20231:45 pmRNSNet Asset Value(s)
8th Dec 202312:18 pmRNSNet Asset Value(s)
7th Dec 20231:07 pmRNSNet Asset Value(s)
6th Dec 20232:45 pmRNSMonth End Net Asset Value(s)
6th Dec 202312:13 pmRNSNet Asset Value(s)
6th Dec 202310:05 amRNSDirector/PDMR Shareholding
5th Dec 202312:16 pmRNSNet Asset Value(s)
5th Dec 20238:43 amRNSDirector/PDMR Shareholding
4th Dec 20231:26 pmRNSGearing disclosure
4th Dec 202312:59 pmRNSNet Asset Value(s)
1st Dec 20237:00 amRNSFourth Interim Dividend
30th Nov 202312:44 pmRNSNet Asset Value(s)
29th Nov 202312:03 pmRNSNet Asset Value(s)
28th Nov 202312:28 pmRNSNet Asset Value(s)
27th Nov 202312:46 pmRNSGearing disclosure
27th Nov 202312:02 pmRNSNet Asset Value(s)
24th Nov 202312:14 pmRNSNet Asset Value(s)
23rd Nov 202311:45 amRNSNet Asset Value(s)
22nd Nov 20232:48 pmRNSNet Asset Value(s)
21st Nov 202312:10 pmRNSNet Asset Value(s)
20th Nov 20232:35 pmRNSGearing disclosure
20th Nov 202312:30 pmRNSNet Asset Value(s)
17th Nov 202311:30 amRNSNet Asset Value(s)
16th Nov 202312:20 pmRNSNet Asset Value(s)
15th Nov 202311:56 amRNSNet Asset Value(s)
14th Nov 202312:40 pmRNSNet Asset Value(s)
14th Nov 202312:21 pmRNSPortfolio disclosure
13th Nov 20234:38 pmRNSGearing disclosure
13th Nov 202312:26 pmRNSNet Asset Value(s)
10th Nov 202312:13 pmRNSNet Asset Value(s)
9th Nov 202312:18 pmRNSNet Asset Value(s)
8th Nov 202311:29 amRNSNet Asset Value(s)
7th Nov 202312:28 pmRNSNet Asset Value(s)
6th Nov 20235:07 pmRNSMonth End Net Asset Value(s)
6th Nov 20232:24 pmRNSGearing disclosure
6th Nov 20231:07 pmRNSNet Asset Value(s)
3rd Nov 202312:36 pmRNSNet Asset Value(s)
2nd Nov 202311:49 amRNSNet Asset Value(s)
31st Oct 202312:48 pmRNSNet Asset Value(s)
30th Oct 20232:54 pmRNSGearing disclosure
30th Oct 202311:59 amRNSNet Asset Value(s)
27th Oct 202312:09 pmRNSNet Asset Value(s)
27th Oct 20237:00 amRNSCompliance with Market Abuse Regulation
26th Oct 202312:48 pmRNSNet Asset Value(s)
26th Oct 202310:09 amRNSDirector/PDMR Shareholding
26th Oct 20237:00 amRNSConclusion of Strategic Review
25th Oct 202312:25 pmRNSNet Asset Value(s)
24th Oct 202312:23 pmRNSNet Asset Value(s)
23rd Oct 20234:14 pmRNSDirector/PDMR Shareholding
23rd Oct 202312:46 pmRNSGearing disclosure

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.